International Stem Cell Corporation (ISCO) operates under a novel business model for the biotechnology industry. This model comprises subsidiary business units that generate revenue from the sale of products developed from scientific discoveries made by ISCO. Not only is this model self-sustaining with the revenues used to support further scientific research and development, but it also provides practical, short-term applications of the core technologies.
To visit Lifeline Cell Technology (LCT) click here
To visit Lifeline Skin Care (LSC) click here